We are live on !
Find out more
Aperio Group Portfolio holdings
AUM
$33.8B
Turnover
6.32%
1-Year Est. Return
31.46%
This Fund
S&P 500
This Quarter Est. Return
+15.94%
1 Year Est. Return
+31.46%
3 Year Est. Return
+70.41%
5 Year Est. Return
+146.06%
10 Year Est. Return
–
AUM
$33.8B
AUM Growth
+$4.19B
(+14%)
Cap. Flow
+$264M
Cap. Flow % of AUM
Cap. Flow %
0.78%
Top 10 Holdings %
Top 10 Hldgs %
21.76%
Holding
2,483
New
104
Increased
1,329
Reduced
987
Closed
53
Avg Time Held
4.6
years
Top 10 Avg Time Held
3.4
years
Top 20 Avg Time Held
3.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Unilever
UL
|
+$52.4M |
| 2 |
Tesla
TSLA
|
+$42.1M |
| 3 |
Microsoft
MSFT
|
+$16.9M |
| 4 |
Walt Disney
DIS
|
+$14.5M |
| 5 |
Morgan Stanley
MS
|
+$11.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Unilever NV New York Registry Shares
UN
|
+$48.8M |
| 2 |
AT&T
T
|
+$25.4M |
| 3 |
Johnson & Johnson
JNJ
|
+$20M |
| 4 |
Amazon
AMZN
|
+$15.7M |
| 5 |
Biogen
BIIB
|
+$12.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.68% |
| 2 | Financials | 13.75% |
| 3 | Healthcare | 13.35% |
| 4 | Consumer Discretionary | 11.59% |
| 5 | Communication Services | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1901
DELISTED
American Woodmark
AMWD
| $570K | ﹤0.01% |
6,071
-402
| -6% | -$36.5K |
2015 Q4
20 quarters
|
|
1902
EchoStar
ECHO
$26.9B
| $567K | ﹤0.01% |
26,776
+14,429
| +117% | +$345K |
2015 Q2
22 quarters
|
|
1903
Zumiez
ZUMZ
$209M
| $567K | ﹤0.01% |
15,417
-431
| -3% | -$14.5K |
2017 Q3
13 quarters
|
|
1904
UroGen Pharma
URGN
$1.73B
| $566K | ﹤0.01% |
31,421
+8,780
| +39% | +$184K |
2020 Q2
2 quarters
|
|
1905
US Physical Therapy
USPH
$1.29B
| $566K | ﹤0.01% |
4,708
-135
| -3% | -$13.6K |
2016 Q1
19 quarters
|
|
|
BSMX
1906
DELISTED
Banco Santander México, S, A., Institución de Banca Múltiple, Grupo Financiero Santander México
BSMX
| $564K | ﹤0.01% |
109,584
-5,952
| -5% | -$26.9K |
2014 Q1
27 quarters
|
|
1907
Children's Place
PLCE
$22.9M
| $563K | ﹤0.01% |
11,239
-2,975
| -21% | -$108K |
2020 Q2
2 quarters
|
|
1908
Shenandoah Telecom
SHEN
$540M
| $563K | ﹤0.01% |
13,028
-777
| -6% | -$34.9K |
2019 Q4
4 quarters
|
|
1909
Cytokinetics
CYTK
$8.74B
| $562K | ﹤0.01% |
27,036
+2,199
| +9% | +$40.2K |
2019 Q2
6 quarters
|
|
1910
TTM Technologies
TTMI
$10.8B
| $562K | ﹤0.01% |
40,764
+3,181
| +8% | +$40.7K |
2015 Q3
21 quarters
|
|
|
SWCH
1911
DELISTED
Switch, Inc. Class A Common Stock
SWCH
| $562K | ﹤0.01% |
34,318
-7,142
| -17% | -$112K |
2018 Q3
9 quarters
|
|
1912
Dillards
DDS
$10.7B
| $560K | ﹤0.01% |
8,881
-966
| -10% | -$47.2K |
2013 Q4
28 quarters
|
|
1913
DELISTED
ProAssurance
PRA
| $560K | ﹤0.01% |
31,503
-12,332
| -28% | -$201K |
2014 Q1
27 quarters
|
|
1914
CareDx
CDNA
$3.66B
| $558K | ﹤0.01% |
7,708
+1,332
| +21% | +$77.2K |
2020 Q3
1 quarter
|
|
1915
Amphastar Pharmaceuticals
AMPH
$1.11B
| $557K | ﹤0.01% |
27,684
+2,768
| +11% | +$53.9K |
2017 Q1
15 quarters
|
|
1916
Camden National
CAC
$953M
| $557K | ﹤0.01% |
15,574
+1,006
| +7% | +$34.6K |
2016 Q4
16 quarters
|
|
1917
Delek US
DK
$4.79B
| $552K | ﹤0.01% |
34,341
-7,760
| -18% | -$102K |
2017 Q3
13 quarters
|
|
1918
Snowflake
SNOW
$114B
| $550K | ﹤0.01% |
+1,956
| New | +$557K |
2020 Q4
0 quarters
|
|
1919
LivaNova
LIVN
$4.32B
| $548K | ﹤0.01% |
8,277
+386
| +5% | +$21.5K |
2017 Q3
13 quarters
|
|
1920
Chatham Lodging
CLDT
$667M
| $547K | ﹤0.01% |
50,645
-8,783
| -15% | -$84.1K |
2019 Q4
4 quarters
|
|
1921
Varonis Systems
VRNS
$5.59B
| $545K | ﹤0.01% |
9,993
+531
| +6% | +$23K |
2020 Q2
2 quarters
|
|
1922
1-800-Flowers.com
FLWS
$170M
| $544K | ﹤0.01% |
20,917
-1,675
| -7% | -$40.7K |
2017 Q4
12 quarters
|
|
1923
First Financial Corp
THFF
$887M
| $544K | ﹤0.01% |
14,008
+2,458
| +21% | +$89.7K |
2016 Q1
19 quarters
|
|
1924
Ethan Allen Interiors
ETD
$499M
| $542K | ﹤0.01% |
26,828
+1,936
| +8% | +$34.1K |
2018 Q1
11 quarters
|
|
1925
Warrior Met Coal
HCC
$4.45B
| $542K | ﹤0.01% |
25,422
-1,708
| -6% | -$30K |
2018 Q3
9 quarters
|
|
Similar funds
LCM
Aperio Group's Q4 2020 Portfolio in Review
As of Q4 2020, Aperio Group held 2,483 positions worth $33.8B, up 14% from $29.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Aperio Group's Q4 2020 filing shows 104 new, 1,329 increased, 987 reduced and 53 closed positions. Its largest new stake was Concentrix: 51,604 shares worth $5.09M. The largest sale was Unilever NV New York Registry Shares, an estimated $48.8M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Financials and Healthcare.
- Aperio Group's largest Q4 2020 buy was Concentrix: 51,604 shares worth $5.09M.
- Aperio Group added most to Unilever in Q4 2020, an estimated $52.4M increase.
- Aperio Group's biggest Q4 2020 reduction was AT&T, cutting an estimated $25.4M.
- Aperio Group fully exited Unilever NV New York Registry Shares in Q4 2020, selling an estimated $48.8M.
- Aperio Group's ten largest holdings make up 22% of its $33.8B portfolio in Q4 2020.
- Aperio Group opened 104 new positions and closed 53 in Q4 2020.
- Aperio Group's portfolio value rose 14% quarter-over-quarter to $33.8B.
Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.